William Blair Investment Management LLC Sells 3,738 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

William Blair Investment Management LLC decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 902,611 shares of the company’s stock after selling 3,738 shares during the period. William Blair Investment Management LLC’s holdings in Inspire Medical Systems were worth $167,326,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Harbour Investments Inc. boosted its stake in Inspire Medical Systems by 101.0% during the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company’s stock valued at $37,000 after buying an additional 99 shares during the period. Monimus Capital Management LP bought a new stake in Inspire Medical Systems during the fourth quarter valued at $5,099,000. Commonwealth Equity Services LLC boosted its stake in Inspire Medical Systems by 7.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 7,984 shares of the company’s stock valued at $1,480,000 after buying an additional 575 shares during the period. Swiss National Bank boosted its stake in Inspire Medical Systems by 1.0% during the fourth quarter. Swiss National Bank now owns 58,600 shares of the company’s stock valued at $10,863,000 after buying an additional 600 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in Inspire Medical Systems by 21.4% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 177,588 shares of the company’s stock valued at $32,921,000 after purchasing an additional 31,344 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Up 2.2 %

INSP opened at $162.26 on Monday. The company has a market cap of $4.81 billion, a P/E ratio of 93.79, a P/E/G ratio of 2.86 and a beta of 1.48. The business’s 50-day moving average price is $184.92 and its 200-day moving average price is $192.07. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. Equities research analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Wells Fargo & Company lowered their price target on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 11th. Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and raised their price target for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Robert W. Baird lowered their price target on Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. KeyCorp restated an “overweight” rating and set a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a research report on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $228.82.

Insider Activity at Inspire Medical Systems

In other news, insider Randy Ban sold 25,584 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the transaction, the insider now owns 7,259 shares of the company’s stock, valued at approximately $1,332,026.50. This represents a 77.90 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CTO John Rondoni sold 583 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now directly owns 10,424 shares of the company’s stock, valued at $1,777,187.76. This represents a 5.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 26,225 shares of company stock worth $4,806,530 in the last 90 days. Company insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.